Plasma untargeted metabolomics reveals promising diagnostic metabolites for adrenocortical carcinoma.

Yang Y, Shi S, Wu J, Xu T, Shang J, Yu J, Zhang B, Liu X.

Open source

DOI
10.3389/fphar.2026.1817514
Published
2026-08-21
Container
Front Pharmacol
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1817514,
  title = {Plasma untargeted metabolomics reveals promising diagnostic metabolites for adrenocortical carcinoma.},
  author = {Yang Y and  Shi S and  Wu J and  Xu T and  Shang J and  Yu J and  Zhang B and  Liu X.},
  year = {2026},
  journal = {Front Pharmacol},
  doi = {10.3389/fphar.2026.1817514},
  url = {https://doi.org/10.3389/fphar.2026.1817514}
}

RIS

TY  - JOUR
TI  - Plasma untargeted metabolomics reveals promising diagnostic metabolites for adrenocortical carcinoma.
AU  - Yang Y
AU  -  Shi S
AU  -  Wu J
AU  -  Xu T
AU  -  Shang J
AU  -  Yu J
AU  -  Zhang B
AU  -  Liu X.
PY  - 2026
JO  - Front Pharmacol
DO  - 10.3389/fphar.2026.1817514
UR  - https://doi.org/10.3389/fphar.2026.1817514
ER  - 

APA

Y, Y., S, S., J, W., T, X., J, S., J, Y., B, Z., & X., L. (2026). Plasma untargeted metabolomics reveals promising diagnostic metabolites for adrenocortical carcinoma.. Front Pharmacol. https://doi.org/10.3389/fphar.2026.1817514

Source records